Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Tvardi Therapeutics (TVRD) vs. Competitors

2,531 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
TVRDTvardi Therapeutics$1.18$15.74M-0.42-71.29%Moderate BuyUnlock the TVRD analyst price target with TipRanks PremiumTVRDUnlock the TVRD top-analyst price target with TipRanks Premium
CUECue Biopharma$16.12$117.10M-0.60-13.28%Moderate BuyUnlock the CUE analyst price target with TipRanks PremiumTVRD vs CUEUnlock the CUE top-analyst price target with TipRanks Premium
ALGSAligos Therapeutics$2.10$14.80M-0.33-65.40%Moderate BuyUnlock the ALGS analyst price target with TipRanks PremiumTVRD vs ALGSUnlock the ALGS top-analyst price target with TipRanks Premium
ANLAdlai Nortye Ltd. Sponsored ADR$10.61$683.26M-5.42602.65%Strong BuyUnlock the ANL analyst price target with TipRanks PremiumTVRD vs ANLUnlock the ANL top-analyst price target with TipRanks Premium

Performance Comparison

-250%0%250%500%750%1000%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
TVRDTvardi Therapeutics1.18-2.85-70.72%
CUECue Biopharma16.12-1.10-6.39%
ALGSAligos Therapeutics2.10-4.92-70.09%
ANLAdlai Nortye Ltd. Sponsored ADR10.619.04575.80%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts